ZYME

Zymeworks Inc.

PDUFA AI-extracted

Ziihera

gastroesophageal adenocarcinoma (GEA)

192d ago Mar 27, 2026

SEC 8-K verified 3mo ago

Countdown card →

ZYME

Zymeworks Inc.

Catalyst AI-extracted

zanidatamab

HER2+ gastric, gastroesophageal junction, or esophageal adenocarcinoma

97d ago ~ Jun 30, 2026

SEC 8-K verified 3mo ago

Countdown card →

ZYME

Zymeworks Inc.

PDUFA Confirmed

zanidatamab

HER2-positive unresectable locally advanced or metastatic gastroesophageal adenocarcinoma (GEA)

41d ago Aug 25, 2026

SEC 8-K verified 3mo ago

Countdown card →

ZYME

Zymeworks Inc.

Approval AI-extracted

zanidatamab

HER2-positive locally advanced or metastatic GEA

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

ZYME

Zymeworks Inc.

Phase 1 AI-extracted

ZW191

platinum resistant ovarian cancer (PROC)

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

ZYME

Zymeworks Inc.

Approval Confirmed

Ziihera

biliary tract cancer

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →

ZYME

Zymeworks Inc.

Phase 3 Confirmed

Ziihera

gastroesophageal adenocarcinoma (GEA)

Date TBD Date TBD

SEC 8-K verified 3mo ago

Countdown card →